AngioDynamics Inc. (ANGO)

20.88
0.08 0.38
NASDAQ : Health Technology
Prev Close 20.96
Open 21.02
Day Low/High 20.79 / 21.24
52 Wk Low/High 15.26 / 24.49
Volume 166.54K
Avg Volume 184.10K
Exchange NASDAQ
Shares Outstanding 37.14M
Market Cap 778.39M
EPS 0.40
P/E Ratio 44.60
Div & Yield N.A. (N.A)

Latest News

AngioDynamics To Report Fiscal 2019 Second Quarter Financial Results On January 4, 2019

AngioDynamics To Report Fiscal 2019 Second Quarter Financial Results On January 4, 2019

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal...

AngioDynamics (ANGO) Shares Cross Below 200 DMA

AngioDynamics (ANGO) Shares Cross Below 200 DMA

In trading on Monday, shares of AngioDynamics Inc crossed below their 200 day moving average of $20.63, changing hands as low as $20.51 per share. AngioDynamics Inc shares are currently trading down about 1.3% on the day.

ANGO Makes Notable Cross Below Critical Moving Average

ANGO Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of AngioDynamics Inc crossed below their 200 day moving average of $19.93, changing hands as low as $19.91 per share. AngioDynamics Inc shares are currently trading down about 1% on the day.

AngioDynamics Reports Fiscal 2019 First Quarter Financial Results

AngioDynamics Reports Fiscal 2019 First Quarter Financial Results

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the first quarter of fiscal year 2019, which...

AngioDynamics To Present At The Cantor Global Healthcare Conference

AngioDynamics To Present At The Cantor Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C.

AngioDynamics To Report Fiscal 2019 First Quarter Financial Results On September 27, 2018

AngioDynamics To Report Fiscal 2019 First Quarter Financial Results On September 27, 2018

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal...

AngioDynamics To Acquire RadiaDyne And Its Revolutionary OARtrac® Radiation Dose Monitoring Platform To Further Expand Oncology Portfolio

AngioDynamics To Acquire RadiaDyne And Its Revolutionary OARtrac® Radiation Dose Monitoring Platform To Further Expand Oncology Portfolio

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced an agreement to acquire RadiaDyne, a privately held medical diagnostic...

AngioDynamics To Present At Two Investor Conferences In September

AngioDynamics To Present At Two Investor Conferences In September

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in...

AngioDynamics Provides Updates On Oncology And Vascular Access Businesses

AngioDynamics Provides Updates On Oncology And Vascular Access Businesses

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today provided a corporate update on enhancements made to its Oncology business and...

Oversold Conditions For AngioDynamics (ANGO)

Oversold Conditions For AngioDynamics (ANGO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AngioDynamics Reports Fiscal 2018 Fourth Quarter And Full-Year Financial Results

AngioDynamics Reports Fiscal 2018 Fourth Quarter And Full-Year Financial Results

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, oncology and surgery, today announced financial results for the fourth quarter and fiscal year,...

AngioDynamics To Report Fiscal 2018 Fourth Quarter And Full-Year Financial Results On July 11, 2018

AngioDynamics To Report Fiscal 2018 Fourth Quarter And Full-Year Financial Results On July 11, 2018

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANGO, CCXI, EGN, ETSY, MRVL, PAY, PRTY, WAIR Downgrades: NGS, RES, SYKE, URG Initiations: NODK, SLD Read on to get TheStreet Quant Ratings' detailed report:

AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results

AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced financial results for the...

AngioDynamics To Present At The Needham 17th Annual Healthcare Conference

AngioDynamics To Present At The Needham 17th Annual Healthcare Conference

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C.

AngioDynamics To Report Fiscal 2018 Third Quarter Financial Results On March 29, 2018

AngioDynamics To Report Fiscal 2018 Third Quarter Financial Results On March 29, 2018

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report...

AngioDynamics To Present At The Barclays Global Healthcare Conference

AngioDynamics To Present At The Barclays Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Jim Clemmer,...

AngioDynamics Receives FDA Expedited Access Pathway Designation For The NanoKnife® System For The Treatment Of Stage III Pancreatic Cancer

AngioDynamics Receives FDA Expedited Access Pathway Designation For The NanoKnife® System For The Treatment Of Stage III Pancreatic Cancer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that the United States...

Relative Strength Alert For AngioDynamics

Relative Strength Alert For AngioDynamics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results

AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced financial results for the...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: EVA, FSBC, GTE, SND, UWN Downgrades: ANGO, PCG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

AngioDynamics To Present At The J.P. Morgan Healthcare Conference

AngioDynamics To Present At The J.P. Morgan Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Jim Clemmer,...

AngioDynamics To Report Fiscal 2018 Second Quarter Financial Results On January 4, 2018

AngioDynamics To Report Fiscal 2018 Second Quarter Financial Results On January 4, 2018

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANGO, NKSH, OBCI, RGS, SGMA Downgrades: AIG, GGP Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: B- (Buy)